Search results for "1':2"
showing 5 items of 5 documents
Synthesis of 2H-Imidazo[2',1':2,3] [1,3]thiazolo[4,5-e]isoindol-8-yl-phenylureas with promising therapeutic features for the treatment of acute myelo…
2022
Despite progressive advances in understanding the molecular biology of acute myeloid leukemia (AML), the conventional therapeutic approach has not changed substantially, and the outcome for most patients is poor. Thus, continuous efforts on the discovery of new compounds with improved features are required. Following a multistep sequence, we have identified a new tetracyclic ring system with strong antiproliferative activity towards several haematological cell lines. The new compounds possess structural properties typical of inactive-state-binding kinase inhibitors and are structurally related to quizartinib which is known as type-II tyrosine kinase inhibitor. In particular, the high activi…
NUOVI AGENTI TERAPEUTICI PER IL TRATTAMENTO DI PATOLOGIE EMATOLOGICHE
2019
La presente invenzione si riferisce al campo di nuove molecole tetracicliche, aventi un sistema tetraciclico, e loro impiego come medicamenti di patologie ematologiche in particolare per il trattamento della leucemia mieloide acuta (AML) in pazienti emizigoti FLT3/ITD resistenti alle terapie convenzionali.
NEW THERAPEUTIC AGENTS FOR THE TREATMENT OF HAEMATOLOGICAL PATHOLOGIES
2021
CCDC 190701: Experimental Crystal Structure Determination
2003
Related Article: Young-Shin Kim, So-Young Park, Myung-Eun Suh, Hyun-Jung Lee, D.Schollmeyer|2003|Bioorg.Med.Chem.|11|1829|doi:10.1016/S0968-0896(02)00667-3
CCDC 739863: Experimental Crystal Structure Determination
2010
Related Article: M.M.Gruza, J.-C.Chambron, E.Espinosa, E.Aubert|2009|Eur.J.Org.Chem.|2009|6318|doi:10.1002/ejoc.200900837